Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $4.78 Consensus Target Price from Brokerages
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has earned a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has earned a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target […]
